Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials-Reference-Cited by-同舟云学术

Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials

Published:2016-01-08 Issue:S1 Volume:38 Page:E1863-E1869
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Mehanna Hisham¹,Franklin Natalie²,Compton Natalie³,Robinson Max⁴,Powell Ned⁵,Biswas-Baldwin Nigel⁶,Paleri Vindh⁷,Hartley Andrew⁸,Fresco Lydia⁹,Al-Booz Hoda¹⁰,Junor Elizabeth¹¹,El-Hariry Iman¹²,Roberts Sally¹³,Harrington Kevin¹⁴,Ang K. Kian¹⁵,Dunn Janet¹⁶,Woodman Ciaran¹³

Affiliation:

1. Institute of Head and Neck Studies and Education (InHANSE), School of Cancer Sciences; University of Birmingham; Edgbaston Birmingham United Kingdom

2. Roche Products Ltd, Shire Park; Welwyn Garden City United Kingdom

3. PPD; Granta Park; Great Abington Cambridge United Kingdom

4. Centre for Oral Health Research; Newcastle University; Newcastle-upon-Tyne United Kingdom

5. HPV Oncology Group, Institute of Cancer and Genetics, School of Medicine; Cardiff University; Cardiff United Kingdom

6. GSK; Uxbridge Middlesex United Kingdom

7. Department of Otolaryngology-Head and Neck Surgery, Newcastle upon Tyne Hospitals, NHS Trust, and Northern Institute for Cancer Research; Newcastle University; Newcastle upon Tyne United Kingdom

8. Hall-Edwards Radiotherapy Research Group; Old Queen Elizabeth Hospital; Birmingham United Kingdom

9. Department of Oncology; University Hospitals Coventry and Warwickshire; Coventry United Kingdom

10. Bristol Haematology and Oncology Centre; Bristol United Kingdom

11. Edinburgh Cancer Centre; Western General Hospital; Edinburgh United Kingdom

12. Department of Clinical Research; Synta Pharmaceuticals Corp; Lexington Massachusetts

13. School of Cancer Sciences; University of Birmingham; Edgbaston Birmingham United Kingdom

14. The Institute of Cancer Research; London United Kingdom

15. Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

16. Warwick Clinical Trials Unit; University of Warwick; Gibbet Hill Campus Coventry United Kingdom

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.24336/fullpdf

Reference20 articles.

1. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region;Mehanna;Head Neck,2013

2. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review;Kreimer;Cancer Epidemiol Biomarkers Prev,2005

3. Oropharyngeal carcinoma related to human papillomavirus;Mehanna;BMJ,2010

4. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States;Kim;BMJ,2009

5. HPV vaccination. Inaccurate assumptions about oropharyngeal cancer;Sturgis;BMJ,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the ‘ACT now & check-it-out’ intervention to support patient-initiated follow up for Head and Neck cancer patients;Patient Education and Counseling;2024-02

2. Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study;Clinical Cancer Research;2023-10-23

3. Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): A systematic review and meta‐analysis;Journal of Medical Virology;2023-10

4. Lead Time to Recurrence After Posttreatment Plasma and Saliva HPV DNA Testing in Patients With Low-Risk HPV Oropharynx Cancer;JAMA Otolaryngology–Head & Neck Surgery;2023-09-01

5. Global epidemiologic patterns of oropharyngeal cancer incidence trends;JNCI: Journal of the National Cancer Institute;2023-08-21